R Squared Ltd Boosts Bristol Myers Squibb Stake

Investment firm increases position in pharmaceutical company by 270.9%

Feb. 27, 2026 at 11:49am

Got story updates? Submit your updates here. ›

R Squared Ltd raised its holdings in shares of Bristol Myers Squibb Company (NYSE:BMY) by 270.9% during the third quarter, according to the company's recent 13F filing with the Securities and Exchange Commission. The firm now owns 46,892 shares of the biopharmaceutical company's stock, valued at $2,115,000.

Why it matters

This investment move by R Squared Ltd highlights the firm's confidence in Bristol Myers Squibb's future prospects. As a major player in the pharmaceutical industry, Bristol Myers Squibb's performance is closely watched by investors and analysts.

The details

R Squared Ltd purchased an additional 34,248 shares of Bristol Myers Squibb during the third quarter, bringing its total position to 46,892 shares. This represents approximately 0.9% of R Squared Ltd's total holdings. Bristol Myers Squibb is the 14th largest holding in R Squared Ltd's portfolio.

  • R Squared Ltd made the stock purchases during the third quarter of the year.

The players

R Squared Ltd

An investment firm that manages a portfolio of stocks and other securities.

Bristol Myers Squibb Company

A global biopharmaceutical company focused on discovering, developing and delivering medicines for serious diseases.

Got photos? Submit your photos here. ›

The takeaway

The significant increase in R Squared Ltd's position in Bristol Myers Squibb suggests the investment firm sees strong potential in the pharmaceutical company's future performance and growth prospects.